Identification of tyrosine hydroxylase as a physiological substrate for Cdk5.
Kansy
Janice W
JW
Department of Psychiatry, The University of Texas Southwestern Medical Center, Dallas, TX 75390-9070, USA.
Daubner
S Colette
SC
Nishi
Akinori
A
Sotogaku
Naoki
N
Lloyd
Michael D
MD
Nguyen
Chan
C
Lu
Lin
L
Haycock
John W
JW
Hope
Bruce T
BT
Fitzpatrick
Paul F
PF
Bibb
James A
JA
D000818:Animals; D001665:Binding Sites / Q000187:drug effects; D002417:Cattle; D003042:Cocaine / Q000494:pharmacology; D051360:Cyclin-Dependent Kinase 5; D018844:Cyclin-Dependent Kinases / Q000378:metabolism*; D051937:Dopamine and cAMP-Regulated Phosphoprotein 32; D004791:Enzyme Inhibitors / Q000494:pharmacology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D019950:Mitogen-Activated Protein Kinase 1 / Q000378:metabolism; D048052:Mitogen-Activated Protein Kinase 3; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism; D016297:Mutagenesis, Site-Directed; D017072:Neostriatum / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D009419:Nerve Tissue Proteins / Q000378:metabolism; D009474:Neurons / Q000187:drug effects / Q000201:enzymology; D010750:Phosphoproteins / Q000378:metabolism; D010766:Phosphorylation / Q000187:drug effects; D011687:Purines / Q000494:pharmacology; D051381:Rats; D000077546:Roscovitine; D012646:Self Administration; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology; D013375:Substance Withdrawal Syndrome / Q000201:enzymology; D014446:Tyrosine 3-Monooxygenase / Q000187:drug effects / Q000378:metabolism*
D051937:Dopamine and cAMP-Regulated Phosphoprotein 32; D004791:Enzyme Inhibitors; D009419:Nerve Tissue Proteins; D010750:Phosphoproteins; D011687:Purines; D000077546:Roscovitine; D014446:Tyrosine 3-Monooxygenase; D051360:Cyclin-Dependent Kinase 5; C495906:Cdk5 protein, mouse; C495907:Cdk5 protein, rat; D018844:Cyclin-Dependent Kinases; D019950:Mitogen-Activated Protein Kinase 1; D048052:Mitogen-Activated Protein Kinase 3; D020928:Mitogen-Activated Protein Kinases; D003042:Cocaine